News Briefs
America’s National Cancer Institute (NCI) has acknowledged oleocanthal as a potential nutraceutical for breast cancer and awarded $399,999 to the company, Oleolive, for the development of the phenolic compound as a functional food to prevent breast cancer.
The funds will be used to research the preventative and therapeutic benefits of oleocanthal in triple negative breast cancer (TNBC) recurrence. Around 50,000 women in the United States are diagnosed with TNBC annually.
See Also:Health NewsA new, safe and effective recurrence inhibitor is urgently needed as the current outlook for TNBC patients is bleak due to high recurrence rates, poor overall survival rates and ineffective available treatments.
Oleocanthal experts Khalid El Sayed and Amal Kaddoumi, who are the company’s chief scientists and researchers at the University of Louisiana-Monroe, co-authored a 2017 study which revealed that oleocanthal was effective in preventing cancer and Alzheimer’s disease in mice and had the potential to become an effective dietary supplement for reducing the risk of developing both conditions.
El Sayed told Olive Oil Times the nutraceutical will be made available to patients once the team has established the desired potency and efficacy of the oleocanthal formulation for preventing TNBC recurrence. He said that further funding would be sought to prepare the formulation for clinical trials on humans.
“[I would] certainly recommend consumption of high-quality extra virgin olive oil daily for not only breast cancer survivors and patients but also for normal healthy people to maintain a condition of well-being based on the significant positive health outcomes documented by several clinical trials and epidemiological studies,” he said.
His recommendation was an average daily consumption of around 20 to 50 milliliters of olive oil per day, depending on an individual’s health and the quality of olive oil consumed. He advised new consumers of olive oil to start with smaller amounts (five to 10 milliliters) and gradually increase the daily dose over time.
More articles on: breast cancer, cancer prevention, oleocanthal
Jul. 29, 2024
Researchers Introduce AI Tool to Help Olive Farmers Predict Harvest Timing
Using machine learning to analyze a range of data points from model farms, researchers were able to predict the timing of the olive harvest with 90 percent accuracy.
Mar. 25, 2024
Scientists Defend Study Finding Xylella Not Responsible for Most OQDS
Margherita Ciervo and Marco Scortichini defend their research that found Xylella fastidiosa was not responsible for most Apulian olive tree deaths over the past decade.
Dec. 2, 2024
IUCN Studies the Tradeoffs Between Intensive and Traditional Olive Groves
The organization found that traditional groves are better for biodiversity but less profitable. Intensive groves are more cost-efficient but create massive monocultures.
May. 7, 2024
Mediterranean Diet and Exercise Associated with Better Gut Health in Older Adults
The study demonstrated these improvements to gut health yielded significant cardiovascular health benefits in older Mediterranean adults.
May. 13, 2024
Study Sheds Light on Lowering Harvest Costs for Table Olive Producers
A combined canopy and trunk shaking method to harvest table olives increases efficiency by 75 percent and improves fruit quality.
Feb. 1, 2024
Olive Oil Metabolites Linked with Improved Cardiovascular Disease Outcomes
The research demonstrated a link between virgin olive oil metabolite profiles and reduced risk of cardiovascular disease, but not diabetes.
Apr. 3, 2024
Uruguay to Host Conference on Olive Oil Sector Research, Innovation
Scientists, producers and officials will meet in Uruguay in November to discuss the challenges and opportunities for South America’s olive oil sector.
Mar. 6, 2024
Xylella May Not Be Responsible for Olive Tree Devastation in Puglia, Study Finds
The findings could unravel a decade of policy and understanding that Xylella fastidiosa was the leading cause of Olive Quick Decline Syndrome in Puglia.